Governor O'Malley Announces $200 Million Investment In Maryland By Top Brazilian Pharmaceutical Company

SourcePR Newswire/Office of Governor O'Malley
Date Published12/03/2013
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Brace Pharmaceuticals
Parent companyEMS S/A
Reshoring category:Transplant
Year reshoring announced:2013
Capital investment ($):200
Country(ies) from which reshored:Brazil
City reshored to:Rockville
State(s) reshored to:MD
Industry(ies):Other, pharma/biotech investment
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, Skilled workforce availability/training
Find Reshoring Articles